Focused on the development of novel targeted medicines to validated anti-cancer and fibrosis targets in areas of unmet need.
Redx Pharma uses its proven drug discovery expertise to generate development candidates that it will take into the clinic. The company’s product development strategy has three interrelated components: cancer, fibrosis, and research.
We formed a strategic collaboration with Redx Pharma for a biomarker project which aims to accelerate therapeutic development for idiopathic pulmonary fibrosis – read the press release.
